What is MedinCell S.A?
, a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.15B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.